In a study on a model of ALS transgenic mice expressing the mutant forms of SOD1 (G93A H1 high-expressor strain), sodium phenylbutyrate showed good efficacy by inhibiting programmed cell death and ameliorating disease progression [134]. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.